Increased Expression of Proinflammatory Chemokines in Bronchoalveolar Lavage Cells of Patients with Progressing Idiopathic Pulmonary Fibrosis and Sarcoidosis

Journal of Investigative Medicine

Volumn 46, Issue 5, 1998, Pages 223-231

  Ziegenhagen, Manfred W ^a   Schrum, Silke ^b   Zissel, Gernot ^a   Zipfel, Peter F ^b   Schlaak, Max ^a   Müller Quernheim, Joachim ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

^b BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

Idiopathic pulmonary fibrosis; IL 8; MIP 1 ; Sarcoidosis; TNF

Indexed keywords

CHEMOKINE; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; GENETICS; HUMAN; IMMUNOLOGY; LUNG FIBROSIS; LUNG LAVAGE; MIDDLE AGED; SARCOIDOSIS;

ADULT; AGED; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES; HUMANS; INTERLEUKIN-8; MACROPHAGE INFLAMMATORY PROTEIN-1; MIDDLE AGED; PULMONARY FIBROSIS; RNA, MESSENGER; SARCOIDOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032084906     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Walker C, Bauer W, Braun RK, Menz G, Braun P, Schwarz F, Hansel TT, Villiger B. Activated T cells and cytokines in bronchoalveolar ravages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med 1994;150:1038-48.
2. Bachwich PR, Lynch JP, Larrick J, Spengler M, Kunkel SL. Tumor necrosis factor production by human sarcoid alveolar macrophages. Am J Pathol 1986;125:421-5.
3. Muller-Quernheim J, Pfeifer S, Mannel D, Strausz J. Ferlinz R. Lung restricted activation of the alveolar macrophage/monocyte system in pulmonary sarcoidosis. Am Rev Respir Dis 1992;145:187-92.
4. Schroeder JM, Mrowietz U, Morita E, Christophers E. Purification and partial biochemical characterization of a human monocyte-derived neutrophil-activating peptide that lacks interleukin-1 activity. J Immunol 1987;139:3474-83.
5. Carre PC, Mortenson RL, King TE Jr, Noble PW, Sable CL, Riches DWH. Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. J Clin Invest 1991;88:1802-10.
6. Lynch JP, Standiford TJ, Rolfe MW, Kunkel SL, Stricter RM. Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8. Am Rev Respir Dis 1992;145:1433-9.
7. Car BD, Meloni F. Luisetti M, Semenzato G. Gialdroni-Grassi G. Walz A. Elevated IL-8 and MCP-1 in the bronchoalveolar ravage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Crit Care Med 1994;149:655-9.
8. Takizawa H, Satoh M, Okazaki H, Matsuzaki G, Suzuki N, Ishii A, Suko M, Okudaira H, Morita Y, Ito K. Increased IL-6 and IL-8 in bronchoalveolar ravage fluids (BALF) from patients with sarcoidosis: correlation with the clinical parameters. Clin Exp Immunol 1997;107:175-81.
9. Southcott AM, Jones KP, Li D, Majumdar S. Cambrey AD, Pantelidis P. Black CM, Laurent GJ, Davies BH, Jeffery PK, et al. Interleukin-8. Differential expression in lone fibrosing alveolitis and systemic sclerosis. Am J Respir Crit Care Med 1995;151:1604-12.
10. Nakamura H, Fujishima S, Waki Y, Urano T, Sayama K, Sakamaki F, Terashima T, Soejima K, Tasaka S, Ishizaka A, et al. Priming of alveolar macrophages for interleukin-8 production in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1995;152:1579-86.
11. Girgis RE, Basha MA, Maliarik M, Popovich J Jr, Iannozzi MC. Cytokines in the bronchoalveolar lavage fluid of patients with active pulmonary sarcoidosis. Am J Respir Crit Care Med 1995;152:71-5.
12. Pantelidis P, Southcott AM, Black CM, Du Bois RM. Up-regulation of IL-8 secretion by alveolar macrophages from patients with fibrosing alveolitis: a subpopulation analysis. Clin Exp Immunol 1997;108:95-104.
13. Fahey III T, Tracey K, Tekamp, Olson P, Cousens L, Jones W, Shires G, Cerami A, Sherry B. Macrophage inflammatory protein 1 modulates macrophage function. J Immunol 1992;9:2764-9.
14. Standiford T, Rolfe M, Kunkel S, Lynch III J, Burdick M, Gilbert A, Oringer M, Whyte R, Strieter R. Macrophage inflammatory protein-1α expression in interstitial lung disease. J Immunol 1993;151:2852-63.
15. Wolpe S, Davatalis G, Sherry B, Beutler B, Hesse G, Nguen H, Moldawer L, Nathan C, Lowry S, Cerami A. Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J Exp Med 1988;167:570-81.
16. Rot A, Krieger M, Brunner T, Bischoff S, Schall T, Ca D. RANTES and macrophage inflammatory protein lot induce the migration and activation of normal human eosinophil granulocytes. J Exp Med 1992;176:1489-95.
17. Schall T, Bacon K, Camp R, Kaspari J, Goeddel D. Human macrophage inflammatory protein-la and MIP-β chemokines attract distinct populations of lymphocytes. J Exp Med 1993;177:1821-5.
18. Stricter R, Chensue S, Basha M, Standiford T, Lynch J, Baggiolini M, Kunkel S. Human alveolar gene expression of interleukin-8 by tumor necrosis factor alpha, lipopolysaccharide and interleukin-1 beta. Am J Respir Cell Mol Biol 1990;2:321-6.
19. Crystal RG, Bitterman PB, Rennard SI, Keogh BA. Interstial lung disease of unknown cause: disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 1984;310:154-6, 235-44.
20. Meier-Sydow J, Weiss S, Buhl R, Rust M, Raghu G. Idiopathic pulmonary fibrosis: current clinical concepts and challenges in management. Semin Respir Crit Care Med 1994;15:77-96.
21. Hunninghake GW, Crystal RG. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med 1981; 305:429-34.
22. Hunninghake GW, Gilbert S, Pueringer R, Dayton C, Floerchinger C, Helmers R, Merchant R, Wilson J, Galvin J, Schwartz D. Outcome of the treatment of sarcoidosis. Am J Respir Crit Care Med 1994;149:893-8.
23. Boutten A, Dehoux MS, Seta N, Ostinelli J, Venembre P, Crestani B, Dombret MC, Durand G, Aubier M. Compartmentalized IL-8 and elastase release within the human lung in unilateral pneumonia. Am J Respir Crit Care Med 1996;153:336-42.
24. Hunninghake GW, Gadek J, Lawley T, Crystal R. Mechanisms of neutrophilic accumulation in the lungs of patients with idiopathic pulmonary fibrosis. J Clin Invest 1981;68:259-69.
25. Costabel U, Bross KJ, Matthys H. The immunoperoxidase slide assay: a new method for demonstration of surface antigens on bronchoalveolar lavage cells. Bull Eur Physiopathol Resp 1985;21:381-7.
26. Schrum S, Probst P, Fleischer B, Zipfel PF. Synthesis of the CC-chemokines MIP-1α, MIP-1β and RANTES is associated with a type 1 immune response. J Immunol 1996;157:3598-604.
27. Standiford TJ, Kunkel SL, Kasahara K, Milia MJ, Rolfe MW, Stricter RM. Interleukin-8 gene expression from human alveolar macrophages: the role of adherence. Am J Respir Cell Mol Biol 1991;5:579-85.
28. Turner-Warwick M, Haslam PM. The value of serial brochoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis. Am Rev Respir Dis 1987;135:26-34.
29. Wells AU, Hansell DM, Corrin B, Harrison NK, Goldstraw P, Black CM, du Bois RM. High resolution computed tomography as a predictor of lung histology in systemic sclerosis. Thorax 1992;47:508-12.
30. Ziegenhagen MW, Benner UK, Zissel G, Zabel P, Schlaak M, Müller-Quernheim J. Sarcoidosis: TNF-α release of alveolar macrophages and serum level of sIL2R are prognostic markers. Am J Respir Crit Care Med 1997;156:1586-92.
31. Zissel G, Homolka J, Schlaak J, Schlaak M, Mfiller-Quernheim J. Antiinflammatory cytokine release by alveolar macrophages in pulmonary sarcoidosis. Am J Respir Crit Care Med 1996;154:713-9.
32. Zissel G, Ernst M, Schlaak M, Müller-Quernheim J. Accessory function of alveolar macrophages from patients with sarcoidosis and other granulomatous and nongranulomatous lung diseases. J Investig Med 1997;45:75-86.
33. Ziegenhagen MW, Zabel P, Zissel G, Schlaak M, Müller-Quernheim J. Serum level of interleukin-8 is elevated in idiopathic pulmonary fibrosis and indicates disease activity. Am J Respir Crit Care Med. 1998;157:762-8.
34. Walters LC, Schwarz MI, Cherniack RM, Waldron JA, Dunn TL, Stanford RE, King TE Jr. Idiopathic pulmonary fibrosis. Pretreatment bronchoalveolar lavage cellular constituents and their relationship with histopathology and clinical response to therapy. Am Rev Respir Dis 1987;135:696-704.
35. Fujimoto K, Kubo K, Yamaguchi S, Honda T, Matsuzawa Y. Eosinophil activation in patients with pulmonary fibrosis. Chest 1995;108:48-54.